Back
Sonnet BioTherapeutics Holdings, Inc. Stock Price Chart
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
8
SONN
Sonnet BioTherapeutics Holdings, Inc.
Last Price:
$1.26
Seasonality Move:
-4.65%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SONN is experiencing slight buying pressure.
Sonnet BioTherapeutics Holdings, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.26 | Sell |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 3.56 | Sell |
| 200-day SMA: | 3 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.33 | Buy |
| 50-day EMA: | 0.14 | Buy |
| 200-day EMA: | 0.04 | Buy |
Sonnet BioTherapeutics Holdings, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 28.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 4.37) | Sell |
| Bollinger Bands (100): | (2.44 - 5.36) | Sell |
Sonnet BioTherapeutics Holdings, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sonnet BioTherapeutics Holdings, Inc. Stock
Is Sonnet BioTherapeutics Holdings, Inc. Stock a Buy?
-
Sonnet BioTherapeutics Holdings, Inc. share price is 1.26 while SONN 8-day simple moving average is 1.26, which is a Sell signal.
-
The stock price of SONN is 1.26 while Sonnet BioTherapeutics Holdings, Inc. 20-day SMA is 2.11, which makes it a Sell.
-
Sonnet BioTherapeutics Holdings, Inc. 50-day simple moving average is 3.56 while SONN share price is 1.26, making it a Sell technically.
-
SONN stock price is 1.26 and Sonnet BioTherapeutics Holdings, Inc. 200-day simple moving average is 3.00, creating a Sell signal.
SONN Technical Analysis vs Fundamental Analysis
Sell
8
Sonnet BioTherapeutics Holdings, Inc. (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings, Inc. a Buy or a Sell?
-
Sonnet BioTherapeutics Holdings, Inc. stock is rated a SellThe current Sonnet BioTherapeutics Holdings, Inc. [SONN] share price is $1.26. The Score for SONN is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Sonnet BioTherapeutics Holdings, Inc. Stock Info
Market Cap:
7.9M
Price in USD:
1.26
Share Volume:
0
Sonnet BioTherapeutics Holdings, Inc. 52-Week Range
52-Week High:
19.30
52-Week Low:
1.08
Sell
8
Sonnet BioTherapeutics Holdings, Inc. (SONN)
is a Sell
Sonnet BioTherapeutics Holdings, Inc. Share Price Forecast
-
What is the Sonnet BioTherapeutics Holdings, Inc. stock price today?The Sonnet BioTherapeutics Holdings, Inc. stock price is 1.26 USD today.
-
Will SONN stock go up or go down?Sonnet BioTherapeutics Holdings, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Sonnet BioTherapeutics Holdings, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sonnet BioTherapeutics Holdings, Inc. is overvalued.
Is Sonnet BioTherapeutics Holdings, Inc. Stock a Buy?
-
Sonnet BioTherapeutics Holdings, Inc. share price is 1.26 while SONN 8-day exponential moving average is 0.67, which is a Buy signal.
-
The stock price of SONN is 1.26 while Sonnet BioTherapeutics Holdings, Inc. 20-day EMA is 0.33, which makes it a Buy.
-
Sonnet BioTherapeutics Holdings, Inc. 50-day exponential moving average is 0.14 while SONN share price is 1.26, making it a Buy technically.
-
SONN stock price is 1.26 and Sonnet BioTherapeutics Holdings, Inc. 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of Sonnet BioTherapeutics Holdings, Inc.
Is Sonnet BioTherapeutics Holdings, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.42 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Sonnet BioTherapeutics Holdings, Inc.
Should I short Sonnet BioTherapeutics Holdings, Inc. stock?
-
SONN Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Sonnet BioTherapeutics Holdings, Inc. is a Buy
-
Sonnet BioTherapeutics Holdings, Inc. Relative Strength Index (RSI) is 28.16, which suggest Sonnet BioTherapeutics Holdings, Inc. is oversold
-
The Bollinger Bands (25) for Sonnet BioTherapeutics Holdings, Inc. is (1.01 - 4.37), which suggest Sonnet BioTherapeutics Holdings, Inc. is a Sell
-
The Bollinger Bands (100) for Sonnet BioTherapeutics Holdings, Inc. is (2.44 - 5.36), which suggest Sonnet BioTherapeutics Holdings, Inc. is a Sell
* Sonnet BioTherapeutics Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.